Abstract
Protease-activated receptor 2 (PAR2) is a G-protein coupled receptor which is activated upon cleavage of its N-terminal region. PAR2 has been associated with many aspects regarding tumor progression, such as the production of pro-tumoral cytokines. Granulocyte colony-stimulating factor (G-CSF) is a cytokine essential to neutrophil production and maturation, and it is often overexpressed in tumors. In this study, we evaluated the ability of PAR2 to modulate G-CSF expression. PAR2 and G-CSF were significantly more expressed in metastatic (4T1 and MDA-MB-231) as compared to non-metastatic (67NR and MCF7) breast cancer cell lines. In addition, PAR2 stimulation by a synthetic agonist peptide significantly increased G-CSF gene expression in the metastatic cell lines. Knockdown of PAR2 in 4T1 cells decreased G-CSF expression and secretion. In addition, treatment of 4T1 with the commercial PAR2 antagonist, ENMD-1068, significantly decreased G-CSF expression. cBioPortal analyses of the TCGA database showed a significant co-occurrence of G-CSF and PAR2 gene overexpression in breast cancer samples. In conclusion, our data suggest that PAR2 contributes to G-CSF expression in breast cancer cells, possibly favoring tumor progression.
References
Dec 21, 2000·Cancer Letters·T M SavareseP J Quesenberry
Apr 9, 2004·Blood·Gertrud M HjortoeL Vijaya Mohan Rao
Oct 19, 2004·The Journal of Biological Chemistry·Lan GeKathryn DeFea
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·S R Coughlin
Jun 19, 2007·Urology·Arup Chakraborty, Sushovan Guha
Aug 19, 2007·Cancer·Jaime Morales-AriasEugenie S Kleinerman
Sep 2, 2008·Cancer Research·Henri H VersteegWolfram Ruf
Jun 23, 2009·Oncogene·S SuS Huang
Nov 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Marcin KowanetzNapoleone Ferrara
May 18, 2011·The Journal of Biological Chemistry·Rithwik RamachandranMorley D Hollenberg
Aug 4, 2011·Journal of Thrombosis and Haemostasis : JTH·W RufF Schaffner
Nov 24, 2011·PloS One·Jeremy D WaightScott I Abrams
Apr 3, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rink-Jan LohmanDavid P Fairlie
May 17, 2012·Cancer Discovery·Ethan CeramiNikolaus Schultz
Jul 25, 2012·Journal of Thrombosis and Haemostasis : JTH·T C Carneiro-LoboW Ruf
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Jul 31, 2013·Bioscience Reports·Luize G Lima, Robson Q Monteiro
Jun 7, 2014·Cell·Patrick D HsuFeng Zhang
Aug 19, 2014·Cytokine & Growth Factor Reviews·Linda J Bendall, Kenneth F Bradstock
Mar 31, 2015·Nature·Seth B CoffeltKarin E de Visser
Jul 4, 2015·British Journal of Pharmacology·Scott BoitanoTheodore J Price
Sep 1, 2015·Nature Methods·Miguel A Moreno-MateosAntonio J Giraldez
Nov 18, 2015·Cancer Metastasis Reviews·Marek Z WojtukiewiczKenneth V Honn
May 18, 2016·Nature Cell Biology·Thomas WelteXiang H-F Zhang
Feb 6, 2017·Gynecologic Oncology·Alice ChanakiraJohn P Sheehan
Jul 27, 2017·Scientific Reports·Ana C LealRobson Q Monteiro
Dec 22, 2017·The Journal of Pharmacology and Experimental Therapeutics·Yuhong JiangDavid P Fairlie
Jul 4, 2018·Clinical & Experimental Metastasis·Belinda YeoRobin L Anderson
Aug 11, 2018·Oncotarget·Vitor Hugo de AlmeidaRobson Q Monteiro
Citations
Dec 6, 2018·International Journal of Molecular Sciences·Rosamaria LappanoMarcello Maggiolini
Jul 26, 2019·The Journal of Biological Chemistry·Kaushik DasProsenjit Sen
Sep 26, 2019·Frontiers in Immunology·Tainá GomesRobson Q Monteiro
Mar 19, 2020·Molecular Medicine Reports·Li LiuXiangyang Xiong
Aug 31, 2021·Cancer Letters·Yiming MaHongying Wang